Eris Lifesciences Limited (ERIS.NS)
INR 1401.3
(0.86%)
INR 1401.3
(0.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 70.48 Billion INR | 92.21% |
| 2022 | 36.67 Billion INR | 61.4% |
| 2021 | 22.72 Billion INR | 23.84% |
| 2020 | 18.34 Billion INR | 18.2% |
| 2019 | 15.52 Billion INR | -0.09% |
| 2018 | 15.53 Billion INR | 6.41% |
| 2017 | 14.6 Billion INR | 127.78% |
| 2016 | 6.4 Billion INR | 53.14% |
| 2015 | 4.18 Billion INR | 17.16% |
| 2014 | 3.57 Billion INR | 32.03% |
| 2013 | 2.7 Billion INR | 57.5% |
| 2012 | 1.71 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 70.21 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 70.48 Billion INR | 92.21% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 70.48 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 38.75 Billion INR | 0.0% |
| 2022 Q4 | 36.67 Billion INR | 0.0% |
| 2022 Q2 | 28.69 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 36.67 Billion INR | 61.4% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 22.72 Billion INR | 23.84% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 22.72 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 20.51 Billion INR | 0.0% |
| 2020 FY | 18.34 Billion INR | 18.2% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 18.34 Billion INR | 0.0% |
| 2020 Q2 | 16.84 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 15.52 Billion INR | -0.09% |
| 2019 Q4 | 15.52 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 15.5 Billion INR | 0.0% |
| 2018 Q2 | 15.2 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 15.53 Billion INR | 0.0% |
| 2018 FY | 15.53 Billion INR | 6.41% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 9.08 Billion INR | 0.0% |
| 2017 Q4 | 14.6 Billion INR | 0.0% |
| 2017 FY | 14.6 Billion INR | 127.78% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 FY | 6.4 Billion INR | 53.14% |
| 2016 Q4 | 6.4 Billion INR | 0.0% |
| 2016 Q2 | 5.49 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 4.18 Billion INR | 17.16% |
| 2014 FY | 3.57 Billion INR | 32.03% |
| 2013 FY | 2.7 Billion INR | 57.5% |
| 2012 FY | 1.71 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sigachi Industries Limited | 6.94 Billion INR | -915.454% |
| Ind-Swift Limited | 6.54 Billion INR | -977.028% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -821.263% |
| Sakar Healthcare Limited | 3.88 Billion INR | -1713.63% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 84.361% |
| Innova Captab Limited | 13.2 Billion INR | -433.647% |
| Divi's Laboratories Limited | 154.7 Billion INR | 54.435% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -553.864% |
| Morepen Laboratories Limited | 12.93 Billion INR | -445.067% |
| Mankind Pharma Limited | 119.63 Billion INR | 41.079% |
| Sequent Scientific Limited | 15.4 Billion INR | -357.603% |
| Wanbury Limited | 3.43 Billion INR | -1952.104% |
| Laurus Labs Limited | 83.87 Billion INR | 15.956% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -221.71% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -147.292% |
| Alembic Limited | 23.28 Billion INR | -202.685% |
| Hikal Limited | 24.87 Billion INR | -183.411% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -9.359% |
| Neuland Laboratories Limited | 18.32 Billion INR | -284.644% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -76.48% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 50.909% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -214.063% |
| Themis Medicare Limited | 5.66 Billion INR | -1144.462% |
| RPG Life Sciences Limited | 5.12 Billion INR | -1274.391% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 75.927% |
| Lupin Limited | 239.97 Billion INR | 70.626% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -1821.341% |
| Wockhardt Limited | 76.49 Billion INR | 7.846% |
| Vaishali Pharma Limited | 799.55 Million INR | -8715.928% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -172.989% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -3147.145% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 38.963% |
| FDC Limited | 24.68 Billion INR | -185.599% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 81.81% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -2836.262% |
| Venus Remedies Limited | 6.26 Billion INR | -1024.521% |
| ZIM Laboratories Limited | 4.46 Billion INR | -1477.548% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -480.692% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -6837.074% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -161.322% |
| Shilpa Medicare Limited | 30.93 Billion INR | -127.881% |
| Albert David Limited | 4.97 Billion INR | -1315.453% |
| Ajanta Pharma Limited | 46.38 Billion INR | -51.967% |
| Hester Biosciences Limited | 6.62 Billion INR | -964.221% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -212.714% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -200.385% |
| Gufic Biosciences Limited | 10.92 Billion INR | -545.178% |
| Windlas Biotech Limited | 6.26 Billion INR | -1025.642% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -787.361% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -2211.154% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -2014.075% |
| Granules India Limited | 55.2 Billion INR | -27.674% |
| Aarti Drugs Limited | 24.32 Billion INR | -189.794% |
| Bal Pharma Limited | 3.2 Billion INR | -2100.087% |
| Alkem Laboratories Limited | 155.74 Billion INR | 54.742% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 91.752% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -906.559% |
| Medicamen Biotech Limited | 2.94 Billion INR | -2293.311% |
| Unichem Laboratories Limited | 31.69 Billion INR | -122.407% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -4672.996% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -14871.183% |
| Valiant Laboratories Limited | 3.42 Billion INR | -1956.93% |
| Orchid Pharma Limited | 15.53 Billion INR | -353.63% |
| Medico Remedies Limited | 961.95 Million INR | -7227.631% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -504.995% |
| Ipca Laboratories Limited | 111.01 Billion INR | 36.504% |
| Brooks Laboratories Limited | 904.45 Million INR | -7693.472% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -1641.899% |
| Piramal Enterprises Limited | 826.05 Billion INR | 91.467% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 53.198% |
| NATCO Pharma Limited | 69.06 Billion INR | -2.064% |
| Suven Life Sciences Limited | 2.84 Billion INR | -2374.121% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -3856.138% |
| Strides Pharma Science Limited | 58.39 Billion INR | -20.704% |
| Indoco Remedies Limited | 21.44 Billion INR | -228.658% |
| Alpa Laboratories Limited | 1.82 Billion INR | -3759.803% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -4572.167% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -1268.6% |